APA (7th ed.) Citation

R, T., G, C., A, M., L, F., G, D. L., C, B., . . . S, P. (2026). Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: A multicenter analysis from the Campania Oncological Network (ROC). BMC cancer. https://doi.org/10.1186/s12885-026-16147-3

Chicago Style (17th ed.) Citation

R, Tambaro, et al. "Real-world Outcomes of Second-line Pembrolizumab in Urothelial Carcinoma: A Multicenter Analysis from the Campania Oncological Network (ROC)." BMC Cancer 2026. https://doi.org/10.1186/s12885-026-16147-3.

MLA (9th ed.) Citation

R, Tambaro, et al. "Real-world Outcomes of Second-line Pembrolizumab in Urothelial Carcinoma: A Multicenter Analysis from the Campania Oncological Network (ROC)." BMC Cancer, 2026, https://doi.org/10.1186/s12885-026-16147-3.